-The United Nations Almost 870 million people, or one in eight, are suffering from chronic malnutrition, according to a new United Nations report released today, which shows a sharp decline in the number of undernourished people over the past two decades, but warns that immediate action is still needed to tackle hunger particularly in developing countries. The State of Food Insecurity in the World 2012 (SOFI), which was jointly published by the Food and...

-World Food Programme Global food prices have taken a worrying turn as drought in the United States causes grain prices to surge. In the latest episode of the Food Factor Podcast, we spoke with WFP’s Deputy Director of Food Security Analysis Arif Husain to find out what the third food-price shock in five years means for the fight against hunger. * What are the main factors behind rising food prices this year? The...

-The New York Times India's coalition government just celebrated the third anniversary of its tenure with a self-congratulatory banquet that could not have been more poorly timed: India's currency, the rupee, is falling; investment is down; inflation is rising; and deficits are eating away at government coffers. While short-term growth has slowed but not ground to a halt, India's problems have dampened hopes that it, along with China and other non-Western economies,...

-PTI With key UPA ally Trinamool Congress averse to FDI in retail, finance minister Pranab Mukherjee today said the Centre is trying to build a consensus on it and other contentious issues. "We are working to build a policy consensus on a number of pending issues such as introduction of Goods and Services Tax, further liberalisation of FDI, including in retail, and deepening and strengthening of financial markets for long term investments,"...

Fighting cancer has just become less expensive for millions of Indian patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...